Evidence map›Paper›PMID 41446112›Full record

ArticlebioRxiv : the preprint server for biology2025

Genetic activation of ERK2 recapitulates core neurodevelopmental features of Rasopathy syndromes in mice.

Kassidy E Grover, Zoe R Cappel, Avery Volz, Evelin M Cotella, Kelly Smallwood, Christine A Berryhill, Kimaya R Raje, Austen A Fisher, Mary Claire T Casper, Diana Nardini and 15 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors.

Kassidy E GroverDivision of Experimental Hematology and Cancer Biology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, United States.ORCID 0000-0001-7688-3629
Zoe R CappelDivision of Experimental Hematology and Cancer Biology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, United States.
Avery VolzDivision of Experimental Hematology and Cancer Biology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, United States.
Evelin M CotellaDepartment of Functional and Systems Neuroscience, Instituto Mercedes y Martin Ferreyra INIMEC-CONICET, Universidad Nacional de Córdoba, Córdoba, Argentina.
Kelly SmallwoodThe Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, United States.
Christine A BerryhillDepartment of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, 46202, United States.
Kimaya R RajeDepartment of Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, United States.
Austen A FisherDivision of Experimental Hematology and Cancer Biology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, United States.
Mary Claire T CasperDivision of Experimental Hematology and Cancer Biology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, United States.
Diana NardiniDivision of Experimental Hematology and Cancer Biology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, United States.
Tilat A RizviDivision of Experimental Hematology and Cancer Biology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, United States.
Rosa M SalazarDivision of Experimental Hematology and Cancer Biology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, United States.
Ashley WootenDivision of Experimental Hematology and Cancer Biology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, United States.
Michael T WilliamsDepartment of Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, United States.
Charles V VorheesDepartment of Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, United States.
Lindsey E RomickDivision of Pathology and Laboratory Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, 45229, United States.
Kenneth D GreisUniversity of Cincinnati Cancer Center, University of Cincinnati College of Medicine, Cincinnati, OH, 45229, United States.
Yueh-Chiang HuDepartment of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, 45229, United States.
Linde A MilesDivision of Experimental Hematology and Cancer Biology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, United States.
Steven P AngusDepartment of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, 46202, United States.
Nancy RatnerDivision of Experimental Hematology and Cancer Biology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, United States.
Carlos E PradaEdwards Family Division of Genetics and Rare Diseases, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, 60611, United States.
K Nicole WeaverThe Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, United States.
Ronald R WaclawDivision of Experimental Hematology and Cancer Biology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, United States.
J Elliott RobinsonDivision of Experimental Hematology and Cancer Biology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, United States.ORCID 0000-0001-9417-3938

Funding

PREDOCTORAL TRAINING PROGRAM IN THE NEUROSCIENCEST32NS007453 · NINDS · UNIVERSITY OF CINCINNATI · PI HERMAN, JAMES P · 1997 to 2025
$4.0M
Midbrain pathways for visual hypersensitivity in neurofibromatosis type 1R01NS126108 · NINDS · CINCINNATI CHILDRENS HOSP MED CTR · PI John Elliott Robinson · 2023 to 2026
$1.5M
An Orbitrap Mass Spectrometry System for the University of Cincinnati Proteomics LaboratoryS10OD026717 · OD · UNIVERSITY OF CINCINNATI · PI GREIS, KENNETH DONALD · 2019 to 2019
$816k
NIH HHS S10 OD026717NINDS NIH HHS R01 NS126108NINDS NIH HHS T32 NS007453
6 · The paper itself

Abstract

Germline pathogenic variants that activate the Ras/mitogen-activated protein kinase (MAPK) pathway cause neurodevelopmental disorders called 'Rasopathies'. Because many affected proteins directly regulate Ras, causative mutations may alter other Ras-dependent pathways in addition to MAPK signaling. To better understand which Rasopathy sequelae result from hyperactivation of downstream MAP kinases, we engineered mice with a gain-of-function mutation in the terminal MAP kinase gene

Identifiers

PMID41446112
PMCPMC12724492

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.